Desmoplastic small round cell tumour of the uterus: a case report by Nur Zaiti Md Arshad, et al.
Desmoplastic small round cell tumour                           Nur Zaiti MA et al. 
https://doi.org/10.17576/JSA.2017.0701.09 
Journal of Surgical Academia 2017; 7(1): 47-50   47 
 
 
 
 
 
Desmoplastic Small Round Cell Tumour of the Uterus: A Case Report 
 
Nur Zaiti MA 
 
(), Mohd Rushdan MN, Lee SJ  
Deptartment of Obstetric & Gynaecology, Hospital Sultanah Bahiyah, Km 6, Jalan Langgar, 05460 Alor 
Setar, Kedah, Malaysia. 
  
Abstract 
 
Desmoplastic small round cell tumour (DSRCT) is a very rare malignant tumour which commonly presented as an 
intraabdominal tumour. It has a distinct histological and immunophenotypic characteristic which differentiates it 
from other types of small blue cell tumour such as Ewing’s sarcoma, primitive neuroectodermal tumour, 
neuroblastoma and malignant mesothelioma. Apart from the abdomen, it may also originate from other region of the 
body including the reproductive organs. 
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Introduction 
 
Desmoplastic small round cell tumour (DSRCT) is a 
type of small roundcell neoplasm that has features 
similar to Ewing or primitive neuroectodermaltumours 
(PNET), but less responsive to the current 
chemotherapeutic agents (1). This rare and highly 
aggressive neoplasm usually diagnosed in males 
during adolescence or in their early adulthood.  
 
Desmoplastic small round cell tumour (DSRCT) was 
first described by Gerald and Rosai in 1989. It is a 
rare, highly malignanttumour with male 
preponderance (1). This aggressive tumour may arise 
from the abdomen, ovaries, liver, kidneys and brain 
(2). We reported a case of a 69 year old 
postmenopausal lady with DSCRT arising from the 
corpus uterine. 
 
Case Report 
 
A 69-years-old lady, para 5, postmenopausal for 
nineteen years, was referred to Gynaeoncology Clinic 
complaining of postmenopausal bleeding and 
gradually increasing abdominal mass for 8 months. 
She also had intermittent abdominal pain, early satiety 
and abdominal fullness. 
 
On examination, there was a huge abdominal mass 
equivalent to 36 weeks size gravid uterus. The mass 
was mobile side to side with regular surface and hard 
in consistency. The vagina and cervix were normal. 
Her CA 125 level was 65.9 (high) and CA 19-9 was 
6.6 (normal). Transabdominal scan showed a large 
multiloculatedmass with cystic, solid areas and 
papillary projection. A large pelvic tumour suspicious 
of ovarian malignancy was seen on CT scan (Fig. 1). 
No ascites or pelvic lymph nodes enlargement seen. 
 
A total abdominal hysterectomy bilateral 
salphingoopherectomy with pelvic lymph nodes 
dissection was done. Intraoperatively the uterus was 
enlarged at 36 weeks size with areas of necrosis over 
posterior serosal layer of the uterus. Both ovaries were 
normal, the cervix and vagina were free from tumour. 
Microscopic examination showed extensive necrosis 
(>50%). The viable cells are small and harbor 
moderate nuclear pleomorphism with inconspicuous 
nucleoli. The cytoplasm is scanty to moderate (Fig. 2). 
No lymphovascular invasion. The tumour infiltrated  
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Figure 1: CT scan showed a large 
uniloculatedintraabdominal mass with cystic and small solid 
area (arrow). 
 
 
 
Figure 2: Microscopic examination showed presence of 
small blue cells with moderate nuclear pleomorphism with 
inconspicuous nucleoli and scanty to moderate cytoplasm 
characteristic of desmoplastic small round cell tumour. 
 
into the myometrium from the serosal aspect with no 
involvement of the lower uterine segment and cervix. 
All lymph nodes were free from malignant cells. 
Immunohistochemical studies showed that the 
malignant cells were diffusely positive for vimentin, 
NSE and WT-1. 
 
Based on the microscopic examination and 
immunohistochemical studies, the final diagnosis was 
Desmoplastic small round cell tumour Stage 1 based 
on FIGO Classification for Corpus Uteri Cancer 2009. 
The patient was discharged well post operatively. No 
further adjuvant chemotherapy or radiotherapy was 
given. Her CA 125 normalized at three weeks after the 
surgery. She recovered well with good performance 
status (ECOG 1). Further assessment at 3 and 6 
months post-surgery showed that patient was well with 
no evidence of recurrence and her biochemical 
markers (CA125) were also normal. 
 
Discussion 
 
Desmoplastic small round cell tumour is a rare, highly 
malignant and aggressive tumour. Commonly 
affecting males with ratio of 4:1(3) in early 20s (4), 
only few reported cases of DSRCT in females were 
published. Less than 30 cases of intraabdominal 
DSRCT in adult women have been reported. Most of 
the patients with DSRCT presented at advanced stage 
hence the survival were poor.  
 
Like the carcinoma of the ovary, most patients with 
DSRCT presented late. The common clinical 
presentation includes abdominal mass, pain, 
compressive symptoms such as constipation and 
incontinence and constitutional symptoms. Clinical 
examination may reveal a palpable huge abdominal 
mass with irregular border and surface and 
intraoperatively the tumour might be located either in 
the abdominal or pelvic cavity. Extensive peritoneal 
involvement with diffuse tumour is also a common 
finding during the surgery (2). DSRCTs may spread 
locally to the peritoneum or omentum and distally to 
the liver, lungs and bone marrow (5). The clinical 
manifestation of DSRCT can mimicked ovarian 
malignancy making the diagnosis difficult without 
surgical evaluation and histopathologic confirmation. 
This patient presented with postmenopausal bleeding 
as the tumour has infiltrated the myometrium.  
 
Desmoplastic small round cell tumour is diagnosed 
based on its distinct characteristic on HPE and IHC. 
The characteristic appearance of undifferentiated small 
blue cells with nuclear pleomorphismand scanty 
cytoplasm is seen microscopically. 
Immunohistochemistry is important in differentiating 
DSRCT from other small round cell tumour. This 
study may reveal the coexpression of epithelial 
(cytokeratin), mesenchymal (vimentin and desmin) 
and neural markers (NSE and neurofilament) in the 
same tumour cell which is diagnostic of DSRCT (6). 
The other marker includes WT1 and CD99 (7).  
 
The management of DSRCT and the impact of the 
treatment modality to the survival rate has only been 
studied in a small number of patient. Surgery, 
chemotherapy,and radiotherapy have been used in the 
treatment of DSRCT (7).  
 
DSRCT with extensive peritoneal involvement makes 
complete surgical resection rarely possible, especially 
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in those with distant metastasis to the liver, hepatic 
veins or involvement of the diaphragm (5). The impact 
of surgery upon survival remains unclear however if a 
complete resection is achieved, the survival rate 
improved especially without metastatic spread (8). 
Hassan et al. found that the patients with DSRCT who 
underwent surgical excision has 34 months survival 
rate as compare to 14 months in those who had 
undergone biopsy only (9). It was also found that 
patients who undergone gross tumour resection has 
improved survival (10). Debulking surgery has a role 
in symptomatic relief from the compressive effect of 
the tumour. 
 
The response of DSRCT to conventional 
chemotherapy regime is poor (7). Multidrugs 
chemotherapyhas been used in DSRCT however none 
have shown curative outcomes (8). Bertuzzi et al. 
found that those with DSRCT had a very poor 
response to multidrug therapy (11). The overall 
response rate from DSRCT group was 43% as 
compared to overall response of 85% in other small 
round cell tumour groups. Kushner et al. used 
neoadjuvantmultidrug chemotherapy followed by 
debulking surgery (12). All of the patients showed 
some response however no complete pathologic 
responses seen. Thus, debulking surgery to remove the 
bulky tumour and multidrug therapy offers a better 
prognosis longer progression-free interval (12). 
 
Radiotherapy has not been used as a primary therapy 
in DSRCT (7). Radiotherapy has been used in 
combination with surgery and chemotherapy but not 
alone. A combination of chemotherapy, surgical 
debulking, and external beam radiation used in a study 
found an overall survival of 48% (13). The median 
time to relapse was 19 months and the most common 
site of recurrence is intraperitoneal and/or hepatic 
recurrence. 
 
Conclusion 
 
Desmoplastic small round cell tumour is a rare 
aggressive tumour which may also arise from the 
reproductive organs. Though it is rare, and clinical 
presentation may mimic other types of uterine 
malignancy, DSRCT should be considered in patients 
presented with advanced malignancy as it 
demonstrates distinct histological features and unique 
cytogenetic profile as compared to other types of small 
cell tumour. There were limited reports on best 
treatment option for DSRCT due to small number of 
reported cases and most patients presented at late 
stage, hence had a poor outcome. However complete 
surgical resection in early disease appears promising 
for a better survival. As for this patient, she presented 
at early stage with complete surgical resection and she 
is diseased free for almost one year up to date, we are 
optimistic for a longer survival rate though the long 
term sequelae of the disease is yet to be evaluated. 
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